Skip to main content

Table 3 Concentrations of CRP according to the HNF1A G319S carrier status among participants without diabetes

From: Assessing the association of the HNF1A G319S variant with C-reactive protein in Aboriginal Canadians: a population-based epidemiological study

 

Beta

SE

CRP [95% CI] (mg/L) *

p

   

G/G319

S/G + S/S319

 

Model 1†

-0.3525

0.1498

1.65 (1.23-2.22)

1.16 (0.93-1.46)

0.02

Model 2‡

-0.2803

0.1351

1.65 (1.26-2.15)

1.24 (0.95-1.62)

0.04

Model 3§

-0.3310

0.1215

1.66 (1.31-2.11)

1.19 (0.94-1.51)

0.007

Model 4∥

-0.2635

0.1008

1.64 (1.35-2.00)

1.26 (1.04-1.54)

0.009

  1. *Least square mean CRP values are back-transformed after using log-transformed CRP to calculate p-values. Group sample sizes of 477 (G/G319) and 104 (S/G + S/S319) have 90.8% power to detect a difference between mean CRP concentrations ± standard deviations of 1.65 (G/G319) ± 1.39 and 1.16 (S/G + S/S319) ± 1.36 at a significance level of 0.05. †Model 1: unadjusted ‡Model 2: adjusted for age, sex, log 2-h post-load glucose §Model 3: adjusted for model 2 variable and waist circumference ∥Model 4: adjusted for model 3 variables and log serum amyloid A